In the months that followed, more news about Thalidomide continue to flow in.
后来的几个月里，继续传来有关萨立多胺的消息。
Objective To study the side effects of thalidomide in treating malignant plasmacyte disease.
目的进一步认识反应停在治疗恶性浆细胞疾病时可能出现的不良反应。
OBJECTIVE: to evaluate research progress and the usage of thalidomide in hematologic disease.
目的：评价沙利度胺在血液病中的研究进展及应用概况。
Clinical studies have confirmed that refractory Crohn disease patients respond to thalidomide.
临床研究证实，难治性克罗恩病的患者对沙利度胺的治疗有所反应。
Controversial drug thalidomide does not improve survival for lung cancer patients, UK scientists say.
英国科学家称，有争议的药物萨立多胺并不能提高肺癌患者的生存机率。
AIM: To investigate the therapeutic effects and mechanism of thalidomide on hepatic fibrosis in rats.
目的：观察沙利度胺对大鼠实验性肝纤维化的治疗效果并探讨其作用机制。
Objective: To observe the curative effect and safety of thalidomide in treating multiple myeloma (MM).
目的：观察沙利度胺联合化疗治疗多发性骨髓瘤(MM)的疗效和安全性。
Patients who took other treatments, like thalidomide and interferon-alpha, had no higher risk, researchers said.
研究者指出，患者采用其他的治疗药物，比如萨利多胺或干扰素，所带来的风险要小一些。
Scientists have discovered the primary mechanism by which thalidomide causes malformed limbs in developing embryos.
科学家已发现在胚胎发育过程中由萨立多胺所引发的畸形肢体的初步原因。
This article summarizes the application and mechanism of action of thalidomide in the treatment of some skin diseases.
介绍了沙利度胺在皮肤病治疗中的应用和作用机制等方面的进展。
Objective to assess the influences of thalidomide on function of endothelial cells in patients with hematologic tumors.
目的探讨沙利度胺对血液肿瘤患者内皮细胞功能的影响。
Scraping line method and MTT were used to observe the effect of angiostatin and thalidomide on proliferation and migration of LEC.
采用划线法和MTT法观察血管生成抑制素和反应停对淋巴管内皮细胞增殖和游走的影响。
Conclusions Thalidomide in combination with chemotherapy is an effective new approach to treating patients with refractory recurrent NHL.
结论反应停联合化疗治疗复发难治nhl疗效较好，是一种有效、值得探索的新方法。
If thalidomide were invented today, it would never he released for human use because new tests on pregnant animals would reveal the dangers.
如果萨立多胺是今天发明的，它就决不会用在人身上，因为对怀孕的动物的新试验将会发现这种危险。
Meanwhile the clinical symptoms in thalidomide group improved faster, and the improvement of liver function was comparable with control group.
沙利度胺组临床症状改善较快，退黄时间和转氨酶下降速度与对照组相近。
Thalidomide was first introduced to the market in 1956 as a sedative, but was abandoned soon because it was correlated with severe birth defects.
沙利度胺作为一种镇静剂于1956年上市，但是由于其致畸的副作用而很快被禁用。
And there's some evidence linking the use of prescription drugs — such as thalidomide and valproic acid — during pregnancy with a higher risk of ASDs.
此外也有证据表明怀孕期服用处方药如沙利度胺和丙戊酸会使婴儿面临较高的罹患asd的风险。
Agents such as sulfasalazine, corticosteroids, azathioprine, TNFa antagonists and thalidomide should be tried first before surgery, except in emergencies.
在进行手术前(除急诊外)，应尝试使用药物如柳氮磺吡啶、激素、硫唑嘌呤、肿瘤坏死因子拮抗剂及反应停。
Methods the rare side effects of thalidomide in treating 4 cases of malignant plasmacyte disease were investigated and the pertinent literatures were reviewed.
方法总结应用反应停治疗恶性浆细胞疾病时见到的4例罕见不良反应的患者，并进行相关文献复习。
As it turned out, the drug (better known by its generic name, thalidomide) would cause thousands of children in Europe to be born limbless or wi flipperlike arms and legs.
事实证明，这种药物（最好了解它的通用名：萨力多胺）会引起上千出生在欧洲的新生儿生来无肢或肢体发育畸形。
Because thalidomide causes severe birth defects if taken during pregnancy, this drug can only be obtained through a special program run by the drug company that makes it.
如果孕期服用沙立度胺可导致严重的先天性缺陷，这一药物只能通过生产它的药物公司的特殊程序获得。
Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable prodrugs, salts, solvates, hydrates, or clathrates are disclosed.
本发明公开了沙利度胺及其药学可接受的前药、盐、溶剂化物、水合物或包合物的药物组合物和单一单位剂型。
Objective: To study the efficacy of combined capecitabine with thalidomide in treatment of advanced colorectal cancer and expression of thymidine phosphorylase in colorectal cancer tissue.
目的：探讨卡培他滨联合沙利度胺治疗晚期结直肠癌的近期疗效及癌组织胸苷磷酸化酶的表达。
RESULTS Treated with angiogenesis inhibitor thalidomide, the basement membrane of capillary became unintegrated, the endothelial cells degenerated, and the procedure of angiogenesis was damaged.
目的为探讨血管形成抑制剂反应停对增生性瘢痕的治疗机制提供形态学依据。
RESULTS Treated with angiogenesis inhibitor thalidomide, the basement membrane of capillary became unintegrated, the endothelial cells degenerated, and the procedure of angiogenesis was damaged.
目的为探讨血管形成抑制剂反应停对增生性瘢痕的治疗机制提供形态学依据。
应用推荐